RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 92 filers reported holding RUBIUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 24 | -99.9% | 0.00% | – |
| Q1 2022 | $158,000 | -39.0% | 28,617 | +6.5% | 0.00% | – |
| Q4 2021 | $259,000 | -43.8% | 26,874 | +4.2% | 0.00% | – |
| Q3 2021 | $461,000 | -22.1% | 25,783 | +6.4% | 0.00% | – |
| Q2 2021 | $592,000 | +10.4% | 24,230 | +19.8% | 0.00% | – |
| Q1 2021 | $536,000 | +123.3% | 20,231 | -36.1% | 0.00% | – |
| Q4 2020 | $240,000 | +185.7% | 31,671 | +87.1% | 0.00% | – |
| Q3 2020 | $84,000 | -30.6% | 16,925 | -15.9% | 0.00% | – |
| Q2 2020 | $121,000 | +70.4% | 20,122 | +25.8% | 0.00% | – |
| Q1 2020 | $71,000 | -54.5% | 15,992 | -2.8% | 0.00% | – |
| Q4 2019 | $156,000 | -8.8% | 16,461 | -24.6% | 0.00% | – |
| Q3 2019 | $171,000 | -36.4% | 21,818 | +27.4% | 0.00% | – |
| Q2 2019 | $269,000 | – | 17,128 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 38,296,526 | $290,671,000 | 5.29% |
| HARBOURVEST PARTNERS LLC | 986,878 | $7,490,000 | 2.93% |
| Abbot Financial Management, Inc. | 537,000 | $4,076,000 | 2.35% |
| Artal Group S.A. | 3,778,913 | $28,682,000 | 0.62% |
| HITE Hedge Asset Management LLC | 88,740 | $674,000 | 0.16% |
| Virtus ETF Advisers LLC | 33,793 | $256,000 | 0.11% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 394,909 | $2,997,000 | 0.03% |
| Baillie Gifford | 4,710,061 | $35,749,000 | 0.02% |
| Caption Management, LLC | 86,000 | $652,000 | 0.02% |
| Blueshift Asset Management, LLC | 14,626 | $111,000 | 0.01% |